SELLAS Life Sciences Group's total assets for Q2 2025 were $32.30M, a decrease of -7.58% from the previous quarter. SLS total liabilities were $6.16M for the fiscal quarter, a -14.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.